Значение20212022202320242025TTMДенежный поток от инвестиционной деятельности-12.91 M-5.75 M-5.41 M-892 K416 K476 KДенежный поток от финансовой деятельности222.74 M325 K1.87 M2.16 M2 0000Свободный денежный поток-32.58 M-14.43 M-50.92 M-28.94 M-48.02 M-36.48 M
Barinthus Biotherapeutics plc - American Depositary Shares
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people.